Loading live market data…

Numinus Wellness Inc.

OTC:NUMIF

$0.03433 USD

$0.0 (-1.35%)

Volume
12.4K
Average Volume
166.46K
Market Capitalization
$11M
P/E Ratio
-1.49
Dividend Yield
0.00%
Price Target
$
Year High
$0.06
Year Low
$0.01
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$0.61
Source Headline
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies

Company's clinical research operations and therapist training programs directly positioned to support accelerated research and commercialization timelines Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Numinus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal agencies to accelerate research, access, and regulatory review for psychedelic-based treatments, including psilocybin, ibogaine, MDMA, and LSD.

newsfilecorp.com - 2026-04-20 08:30:00

Get NUMIF Insider Trade Alerts

NUMIF Price Target Summary

Last Month

$

0 analysts

Last Quarter

$

0 analysts

Last Year

$

0 analysts

All Time

$

0 analysts

NUMIF Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade